Implementation of AI in Cancer Care
Radiation Oncology
Prior Authorization
AI / ML Development
AI platform for radiation oncology that automates and validates radiotherapy treatment plans, while providing dosimetry services support.
.avif)
AI-powered prior
authorization solution
that automates patient
eligibility checks
through to submission
and appeals.
Workflow infrastructure
to help clinicians and
health systems
develop, test and
deploy AI seamlessly,
without security risks or
IT bottlenecks.
Building something that revolutionizing Note Taking using AI Scribes? Reach out!
Digital Infrastructure Powering Drug Development
Tumor Biobank +
Real World Evidence
Data Platforms to Enhance
Drug Discovery
Implementation
of Clinical Trials
Leverages advanced computational methods from astrophysics to enable effective discovery and novel usage of cancer biomarkers.
Optimizes genetic
testing in Latin
America -
streamlining test
ordering, consent
collection and result
delivery through
their digital platform.
Built the largest
canine cancer
dataset—creating
a usable,
comparative
oncology platform
to help cancer
researchers
predict therapeutic
effectiveness.
Conduit for usable
data in clinical
research for pharma
sponsors and trial
sites - identifying
and mapping
required data from
the EHR into the
EDC.
Building something that revolutionizes Clinical Trial Enablement? Let's chat.
.avif)
.avif)
As a cancer survivor himself, Ben Freeberg brings the patient perspective & years of industry expertise to the table. With over 40 investors, I am continually impressed by Ben's work ethic and dedication to his portfolio companies. Ben is often the first to respond to an ask, always circles back, and meaningfully mobilizes his resources to help us move the needle forward.
- Kaitlin Christine, CEO of Gabbi
The investment from Oncology Ventures marks a pivotal milestone for BIOMAKERS. Having a prestigious oncology-focused venture capital firm believing in our vision and our ability to revolutionize cancer research and drug development, it’s fuel for our journey ahead. This partnership signifies not only capital but also strategic alignment with a firm that deeply understands the transformative potential of genomic data and precision medicine. I am beyond excited about the synergies we will build together and the impact we will create globally in advancing cancer therapies.
— Nicolas Kirchuk, CEO of Biomakers
Ben’s authentic and genuine desire to transform care of cancer patients was evident in our first meeting. He devoted time to grasp our technology and its diverse uses - a challenge, given its intersection between astrophysics and medicine! It is a privilege to work with partners who meaningfully invest not just capital, but also time, energy and expertise into realising your vision, and we’re delighted to have found such a partner in Oncology Ventures.
— Irina Babina, CEO of Concr
At Daymark Health, we’re creating a new kind of cancer care experience, one that helps patients feel empowered every step of the way. We are grateful to partner with Oncology Ventures, which shares our passion for this mission and has provided us with invaluable support.
— Dr. Justin Bekelman, CEO of Daymark Health
Aligning with Oncology Ventures and Ben Freeberg reflects our shared commitment to closing critical data gaps and accelerating life-saving cures through precision therapeutics—extending innovation to the last miles of care. At FidoCure, we believe transformative care reaches both sides of the leash to our beloved dogs, and this partnership advances that vision dramatically.
— Christina Lopes, CEO of FidoCure
Any founder would be tremendously lucky to have Ben and his team in their corner. Their humanity, humility, and commitment to making a difference set them apart from typical capital partners. From the very first meeting, it was clear Oncology Ventures was going to take the time to truly understand our vision, connect the dots, and to support us in any way they could.
— Dan Caron, Founder, CEO of Health Universe
IgniteData is extremely excited to be part of the OV portfolio of companies! The industry knowledge and expertise on the digital side of healthcare and life sciences is unparalleled from the direct team to the fund advisors and LPs. Success in this space is a combination of understanding value drivers and being connected with the correct buyers, which OV has the capabilities to provide across the ecosystem.
— Zach Taft, CEO of IgniteData
.avif)
We're thrilled to partner with Oncology Ventures as we continue to transform radiation oncology. Their deep expertise in healthcare technology, combined with their strong industry networks, will open doors that accelerate our vision of a world where quality cancer care is accessible to everyone. Beyond capital, their strategic guidance and commitment to innovation make them the ideal partner to help us drive meaningful change in cancer care worldwide.
— Keith Hansen, CEO of Lumonous